Pharmacy Disclosure Log 2020

 

1. Antiretroviral Therapies Response 5560
2. Anit VEGF Treatment Response 5329
3. Biologics & Biosimilar Prescribing in Rheumatology Response 5093
4. Biologics and Biosimilar Products Response 5428
5. Breast Cancer Treatment Response 5445
6. Dermatology Treatment Response 5553
7. Dermatology Treatment Response 5440
8. Dermatology Biologics Response 5140
9. Dispensed Products Response 5256
10. Delirium Response 5373
11. Delirium Response 5373 - Attachment
12. Free of Charge Medication Response 5379
13. Gastro Biologics Response 5124
14. Intra-Vitreal Injections or Implants Response 5303
15. Ophthalmology Prescribing Response 5201
16. Osteoporosis Treatment Response 5250
17. Medication Response 5390
18. Patients being Treated for Metastatic Non-Small-Cell Lung Cancer Response 5313
19. Patients being Treated for Metastatic Non-Small-Cell Lung Cancer Response 5313 - Attachment
20. Patient Group Directive Response 5152
21. Patients Treated for Asthma Response 5249
22. Patients Treated with Specific Drugs Response 5282
23. Patients Treated for Colorectal Cancer Response 5283
24. Patients Treated with Specific Drugs Response 5319
25. Patients Treated for Colorectal Cancer Response 5283 - Attachment
26. Patients Treated for Severe Asthma Response 5383
27. Patients Treated with Specific Drugs Response 5387
28. Prescribing regardless of Diagnosis Response 5262
29. Prescribing Data for CBPMs Response 5098
30. ULMs and UK Unlicensed Specials Response 5142
31. ULMs and UK Unlicensed Specials Response 5142 Attachment
32. Usage Sodium Chloride 5% Response 5121

• Share:
• Facebook
• Twitter
• LinkedIn